Biogen Idec (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced the full results from the Phase 3 DECIDE clinical trial, which show ZINBRYTA™ (daclizumab high-yield process), dosed subcutaneously once …
QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced positive final results from its international, multi-center, Phase 1b clinical trial of repeated treatments of oral QLT091001 in …
Smartphones will soon be able to perform the functions of a ‘pocket doctor’ and map Parkinson’s disease and other degenerative diseases, thanks to the work of an Aston University mathematician.
Building on a successful three-year pilot project, the National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses …
Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection.
Paralympian Ben Quilter has joined a project to inspire youngsters to take up more activities.
Birt-Hogg-Dubé syndrome (BHD)
A blog dedicated to the bone cancer.
Copyright © 2006-2014 CheckOrphan. All rights reserved.
CheckOrphan is a 501(c)(3) nonprofit organization. Contributions to CheckOrphan in the United States and Switzerland are tax-exempt to the extent provided by law.
Powered by GetReelHealth.com
Copyright © 2005-2014